Are you looking to put on muscle and achieve a lean and athletic physique? As a trainer and nutritionist, I have worked with ...

Bimagrumab was shown to result in less total weight loss but better body composition. The fact that medication alone can ...

IF YOUR MAIN FITNESS goal is to add mass and chisel out your figure, then the thought of building "lean muscle" likely sounds rather appealing. After all, why would you dedicate hours in the gym and ...

Weight loss drugs have soared in popularity in the past year, helping some lose dramatic amounts of weight — but not all that weight is fat. Some of that is actually lean mass, which is everything in ...

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

As a new age of weight-loss therapeutics dawns, heralded by the likes of semaglutide (Ozempic, Wegovy), scientists are one step closer to creating a drug that can coax muscles into behaving as if they ...

Many enjoy a fitness "bulking phase" in the winter season. Getting in the gym and lifting more is a great way to spend the year's colder months. However, gaining weight can go wrong, and you find you ...

Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...

As Miami-based Veru continues development of its enobosarm to prevent muscle wasting in patients being treated for obesity, among other conditions, the biopharma has conducted a survey showing that ...

GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...